A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
Clinical trial NCT03928743 · COMPLETED
Trial details
- NCT number
- NCT03928743
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-25
- Primary completion
- 2021-09-03
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.